Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Research and Development Grants

University of Guelph

$39,200.00

Recombinant production of antimicrobial peptides as alternative to antibiotics

EF 2013-14

Résumé
Antibiotic resistance in humans and animals is a growing concern for the public health in Ontario andworldwide. Searching for alternative effective means to overcome antibiotic resistance to treat emerginginfectious diseases is a new challenge. Protegrins (PGs) are a family of antimicrobial peptides that areproduced by the white blood cells in pigs. They have antimicrobial activity against gram-positive and -negative bacteria, mycobacteria, and enveloped viruses such as HIV (15), and therefore possess promising therapeutic potential for treatment of infections. However, chemically synthesized antimicrobial peptides are too expensive to be feasible for routine use in our pork industry. The objective of the project is to establish a cost-effective strategy to produce antimicrobial peptides using microorganisms as hosts. We plan to express a pig antimicrobial peptide, protegrin-1, in both yeast and Lactoccocus lactis (L. lactis) via recombinant DNA approach. The level of antimicrobial peptides produced and secreted by yeast, and L. lactis will be compared, and the most efficient system will be selected for subsequent investigation. The purified recombinant antimicrobial peptides will then be tested for bactericidal activity against both pig and human pathogens. We will also determine whether or not these purified antimicrobial peptides (PGs) can efficiently treat an infection in a bacteria-challenged animal model to assess any potential side effects of this clinical treatment.
Programme
Collaborative Research and Development Grants
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
449796-2013
Name nom
Li, Julang
Department département
Animal and Poultry Science
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
39200
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
101
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal production and animal primary products
Area of application fr
Production animale et produits animaux primaires
Research subject code
5512
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Veterinary sciences
Research subject fr
Médecine vétérinaire
Partie
1
Nb partie
2
Application title
Recombinant production of antimicrobial peptides as alternative to antibiotics
Keyword
NSERC
Application summary
Antibiotic resistance in humans and animals is a growing concern for the public health in Ontario andworldwide. Searching for alternative effective means to overcome antibiotic resistance to treat emerginginfectious diseases is a new challenge. Protegrins (PGs) are a family of antimicrobial peptides that areproduced by the white blood cells in pigs. They have antimicrobial activity against gram-positive and -negative bacteria, mycobacteria, and enveloped viruses such as HIV (15), and therefore possess promising therapeutic potential for treatment of infections. However, chemically synthesized antimicrobial peptides are too expensive to be feasible for routine use in our pork industry. The objective of the project is to establish a cost-effective strategy to produce antimicrobial peptides using microorganisms as hosts. We plan to express a pig antimicrobial peptide, protegrin-1, in both yeast and Lactoccocus lactis (L. lactis) via recombinant DNA approach. The level of antimicrobial peptides produced and secreted by yeast, and L. lactis will be compared, and the most efficient system will be selected for subsequent investigation. The purified recombinant antimicrobial peptides will then be tested for bactericidal activity against both pig and human pathogens. We will also determine whether or not these purified antimicrobial peptides (PGs) can efficiently treat an infection in a bacteria-challenged animal model to assess any potential side effects of this clinical treatment.